PRODUCT DETAIL

Dafiro HCT 10 mg/160 mg/12,5 mg filmom obalené tablety

Code

83704

MA number

EU/1/09/574/023

Product Form:

tbl flm 280x1(4x70)x10 mg/160 mg/12,5 mg (blis.PVC/PVDC-perf.)

MA Status:

E - Valid centralised marketing authorisation

Type of procedure:

Therapeutic Class:

58 - HYPOTENSIVA

ATC:

C	CARDIOVASCULAR SYSTEM
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D	ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
C09DX	Angiotensin II antagonists, other combinations
C09DX01	Amlodipine besylate, valsartan, hydrochlorothiazide

Shelf life:

Container:

blister PVC/PVDC

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10b fixed combination application
MA issued:	04.11.2009
SmPC + PL:	European Medicines Agency's database
Safety feature	Yes
Data update:	22.09.2022